Robert J. Flanagan was elected to W. P. Carey’s Board of Directors in 2018 and serves as Chair of the Audit Committee and a member of the Investment Committee. Mr. Flanagan is the Chair and former CEO & President of Clark Enterprises, Inc., a private investment firm with a diversified portfolio of holdings, including real estate and private equity in Bethesda, Maryland. He previously served as the Managing Director of CNF Investments.

Mr. Flanagan serves as a director of Brown Advisory, Inc. (since 2016) and Vascular Therapies (since 2013). He previously served as Chair and director of Washington, D.C.’s Federal City Council. He previously served as a director of Martek Biosciences Corporation (NASDAQ: MATK), Sagent Pharmaceuticals (NASDAQ: SGNT), Svelte Medical Systems, Verax BioMedical and Clark Equity Investors, Inc. Mr. Flanagan is an advisor of Georgetown University’s McDonough School of Business. He was a trustee of the A. James & Alice B. Clark Foundation and Treasurer, Secretary and a member of the board of directors of the Baltimore Orioles, Inc.

Mr. Flanagan received a B.S. in Business Administration from Georgetown University and an MST from the American University School of Business. He is a Certified Public Accountant licensed in Washington, D.C.